Infant Catheter

Infant Catheter Market Outlook

The global infant catheter market is projected to reach approximately USD 1.2 billion by 2035, expanding at a compound annual growth rate (CAGR) of about 8.5% during the forecast period from 2025 to 2035. This growth can be attributed to various factors, including the increasing prevalence of congenital disorders that require invasive procedures, advancements in catheter technology, and rising awareness regarding neonatal care. Furthermore, the growing demand for minimally invasive procedures in pediatric medicine has bolstered the adoption of infant catheters. Enhancements in healthcare infrastructure and an increase in the number of neonatal intensive care units (NICUs) also play a crucial role in driving market growth. Additionally, the ongoing research and development efforts aimed at improving catheter materials and designs contribute significantly to the market's expansion.

Growth Factor of the Market

One of the primary growth factors driving the infant catheter market is the rising incidence of preterm births globally. According to the World Health Organization, approximately 15 million infants are born preterm each year, leading to increased demand for specialized medical devices like catheters to assist in their care. Furthermore, advancements in neonatal care, such as enhanced monitoring systems and improved catheter designs, have made it easier for healthcare professionals to administer medications and fluids to vulnerable infants safely. The growing focus on research and development in healthcare technology has also led to the introduction of smarter, biocompatible catheter options that minimize the risk of complications, thereby encouraging their usage. Additionally, the increase in healthcare expenditure in emerging economies is likely to enhance the availability and accessibility of such devices, further propelling market growth. The collaboration between medical device manufacturers and healthcare providers to develop tailored solutions for neonatal care is yet another factor influencing the market positively.

Key Highlights of the Market

• The global infant catheter market is projected to grow at a CAGR of 8.5% from 2025 to 2035.
• Increased prevalence of congenital conditions is a significant driver of market growth.
• Technological advancements are leading to the development of safer, more efficient catheter designs.
• Emerging economies are witnessing a rise in healthcare expenditure, enhancing access to neonatal care.
• The growing number of neonatal intensive care units (NICUs) is fostering market expansion.

By Product Type

Central Venous Catheters

Central venous catheters (CVCs) are designed for the delivery of medications, fluids, and nutrients directly into a patient's central circulation. In the context of infants, CVCs are utilized in cases requiring long-term intravenous access, particularly in critically ill neonates who may need continuous medication administration or nutritional support. The increasing prevalence of chronic conditions among infants, such as congenital heart disease, often necessitates the use of CVCs for effective management. Additionally, advancements in CVC technology, such as the use of antimicrobial coatings, have significantly reduced the instances of catheter-related infections, further driving their adoption. Consequently, the CVC segment is expected to hold a significant share of the infant catheter market during the forecast period.

Umbilical Catheters

Umbilical catheters, including umbilical arterial catheters and umbilical venous catheters, are specifically designed for use in newborns. These catheters are inserted into the umbilical cord stump shortly after birth and provide immediate access to the infant's circulatory system. The growing focus on efficient neonatal resuscitation practices and advanced management of critically ill infants has led to heightened demand for umbilical catheters. The ability of these catheters to facilitate blood sampling, medication delivery, and fluid resuscitation in emergency situations significantly enhances their value in neonatal care. As a result, the umbilical catheter segment is anticipated to witness robust growth in the coming years, driven by the increasing emphasis on improving neonatal outcomes.

Peripherally Inserted Central Catheters

Peripherally inserted central catheters (PICC) are gaining traction in the management of infants requiring extended intravenous therapy. These catheters are inserted into a peripheral vein and threaded into the central venous system, providing a route for long-term access to the bloodstream. The rising number of infants requiring long-term antibiotic treatment or total parenteral nutrition (TPN) has led to an increased demand for PICCs. Moreover, the introduction of innovative designs that focus on ease of insertion and reduced complication rates has further fueled their adoption. As healthcare providers seek efficient solutions for managing complex pediatric conditions, the PICC segment is expected to experience significant growth in the infant catheter market.

Umbilical Arterial Catheters

Umbilical arterial catheters (UACs) are vital tools in neonatal care, primarily used for monitoring blood pressure and drawing blood in critically ill newborns. UACs offer immediate access to the arterial system, allowing for real-time assessment and intervention. The growing incidence of preterm births and associated complications necessitates the use of UACs for effective management in NICUs. Moreover, advancements in catheter materials and design have improved the safety and efficacy of UACs, further boosting their demand. As a result, UACs are expected to play a prominent role in the infant catheter market, particularly in settings focused on providing high-quality neonatal care.

Neonatal PICC

Neonatal peripherally inserted central catheters (Neonatal PICCs) are specialized devices designed for the unique vascular anatomy of infants. They provide an essential access point for administering medications, fluids, and blood products in neonates, particularly those requiring long-term treatment. The increasing prevalence of complex medical conditions among newborns has led to a rising demand for Neonatal PICCs. Additionally, technological advancements have resulted in the development of pediatric-friendly designs that facilitate easier insertion and minimize discomfort. The emphasis on improving neonatal care outcomes is expected to propel the growth of the Neonatal PICC segment within the overall infant catheter market.

By Application

Medication Administration

Medication administration is one of the critical applications of infant catheters, as it ensures timely and accurate delivery of essential treatments to neonates. The need for precise medication dosing and administration routes in infants, who may be more sensitive to medications than older populations, drives the importance of using catheters. The increasing incidence of neonatal infections and other medical conditions requiring pharmacological intervention has significantly boosted the demand for catheters designed for medication delivery. Moreover, the advent of smart catheter technology, which allows for better monitoring and control during administration, is further enhancing the efficacy of this application. As healthcare providers increasingly prioritize optimized medication management for critically ill infants, the segment dedicated to medication administration is expected to experience robust growth.

Fluid and Blood Transfusion

The application of infant catheters for fluid and blood transfusion is crucial for managing the hydration and nutritional needs of neonates, particularly those in critical condition. Fluid and blood transfusions are often necessary for preterm infants or those with significant blood loss due to various medical conditions. Catheters provide a reliable route for rapid infusion, ensuring that infants receive the required fluids and blood products without delay. The growing awareness of the importance of timely intervention in neonatal care, especially in cases of sepsis or hemorrhagic shock, is driving the demand for catheters designed for these applications. As a result, the fluid and blood transfusion segment is expected to witness considerable growth, supported by advancements in transfusion technology and best practices in neonatal care.

Sampling and Pressure Monitoring

Sampling and pressure monitoring is another essential application of infant catheters, enabling healthcare providers to assess the physiological status of neonates and make informed treatment decisions. These catheters facilitate the collection of blood samples for diagnostic testing, which is vital for early detection and management of potential health issues in infants. Additionally, many infant catheters are equipped with pressure monitoring capabilities, allowing for continuous assessment of blood pressure and other vital parameters. The increasing focus on personalized medicine and the provision of tailored care for neonates are driving the demand for catheters that can support accurate sampling and monitoring. As healthcare systems continue to improve their neonatal care protocols, the sampling and pressure monitoring application is expected to grow significantly.

By Distribution Channel

Hospitals

Hospitals remain the primary distribution channel for infant catheters, as they house specialized departments such as NICUs that require advanced medical devices for neonatal care. The increasing incidence of neonatal complications and preterm births necessitates the availability of catheters in hospitals to ensure prompt and effective medical intervention. Hospitals are equipped with trained healthcare professionals who can handle the complexities associated with the use of infant catheters safely. Furthermore, the rising investments in hospital infrastructure, including the establishment of more NICUs, are expected to bolster the demand for catheters in this setting. As hospitals continue to prioritize improving neonatal care outcomes, the hospital segment is projected to dominate the infant catheter market.

Clinics

Clinics, particularly those specializing in pediatrics and maternal health, are also becoming important distribution channels for infant catheters. These facilities often serve as the first point of care for newborns requiring immediate medical attention. Clinics that focus on early diagnosis and preventive care for infants are increasingly adopting catheter solutions to facilitate treatment. The growing trend of outpatient care and the emphasis on providing accessible healthcare services are driving the demand for catheters in clinics. As healthcare providers aim to enhance patient outcomes by providing timely interventions, the clinic segment is expected to witness significant growth in the upcoming years.

Ambulatory Surgical Centers

Ambulatory surgical centers (ASCs) serve as vital distribution channels for infant catheters, particularly for minor surgical procedures requiring anesthesia and intraoperative monitoring. The convenience and efficiency of ASCs have led to their popularity in providing surgical care to infants and children. The growing trend of outpatient surgeries and the focus on reducing hospital stays have encouraged healthcare providers to utilize ASCs for various pediatric procedures. The need for reliable and efficient catheter solutions in these settings is driving the demand for infant catheters. As the number of ASCs continues to grow, particularly in urban areas, the segment is expected to see substantial growth in the market.

Homecare Settings

Homecare settings are emerging as a significant distribution channel for infant catheters, especially for families seeking to provide continued care for their newborns outside of traditional healthcare facilities. The increasing emphasis on patient-centered care and the desire for families to manage their infants' medical needs at home are driving the demand for catheters in these settings. Homecare solutions allow for the safe administration of medications and fluids, reducing the need for frequent hospital visits. The growth of telemedicine and remote monitoring technologies further supports the trend of providing care at home. Consequently, the homecare settings segment is anticipated to witness considerable growth, catering to the evolving needs of families and healthcare providers alike.

Online Retailers

Online retailers are becoming increasingly important as distribution channels for infant catheters, offering convenience and accessibility for healthcare professionals and families alike. The rise of e-commerce has transformed the way medical devices are purchased, allowing for easy comparison of products and prices. Online platforms provide a wide selection of catheter options, enabling consumers to find specialized devices suited to their specific requirements. The ongoing digitalization of the healthcare sector is further enhancing the appeal of online retailers, providing timely deliveries and streamlined purchasing processes. As the demand for online shopping continues to grow, this segment is expected to expand considerably in the infant catheter market.

By Material Type

Silicone

Silicone is a prominent material used in the manufacturing of infant catheters due to its biocompatibility and flexibility. This material is well-tolerated by the delicate tissues of infants, minimizing the risk of irritation and adverse reactions. Silicone catheters are designed to provide comfort and reduce complications associated with prolonged use, making them ideal for neonates requiring long-term access. The chemical stability of silicone also ensures that it remains inert in the body, preserving the integrity of the medication or fluid administered. As healthcare providers increasingly prioritize the safety and comfort of infants, the demand for silicone-based catheters is expected to rise significantly within the infant catheter market.

Polyurethane

Polyurethane is another widely used material in infant catheters, known for its strength and durability. This material offers excellent kink resistance, which is essential for maintaining a clear flow path during medication administration or fluid transfusion. Polyurethane catheters can be manufactured in a range of sizes and configurations, making them suitable for various applications in neonatal care. Additionally, the material's lower risk of thrombogenicity compared to other options has made it a preferred choice for many healthcare professionals. As the focus on minimizing complications during catheter use continues to grow, the polyurethane segment is expected to experience notable growth in the market.

Teflon

Teflon, or polytetrafluoroethylene (PTFE), is utilized in specific applications within the infant catheter market due to its excellent non-stick properties and resistance to chemical degradation. Teflon-coated catheters are particularly beneficial in minimizing friction and improving ease of insertion, making them suitable for use in delicate neonatal procedures. The material's biocompatibility and safety profile further enhance its appeal in the pediatric healthcare setting. As the demand for innovative catheter solutions increases, Teflon-based products are expected to carve out a niche within the infant catheter market, particularly for applications requiring precise insertion and enhanced performance.

Polyethylene

Polyethylene is a versatile material commonly used in the manufacturing of various medical devices, including infant catheters. Its affordability and ease of processing make it an attractive option for manufacturers. Polyethylene catheters are lightweight and flexible, offering ease of handling for healthcare professionals. However, they may not be as biocompatible as silicone or polyurethane, which could limit their usage in certain applications. Despite this, polyethylene remains a relevant choice for specific catheter designs where cost-effectiveness is essential. The segment is expected to maintain a moderate presence in the infant catheter market, catering to specific needs within the industry.

PVC

Polyvinyl chloride (PVC) is one of the most commonly used materials in medical device manufacturing, including infant catheters. PVC catheters are known for their affordability and availability, making them a popular choice among healthcare providers. However, concerns regarding the biocompatibility and leachability of certain additives used in PVC manufacturing have led to increased scrutiny. Manufacturers are addressing these concerns by developing more advanced PVC formulations that enhance biocompatibility while maintaining the material's essential properties. The PVC segment is likely to see steady demand in the infant catheter market, particularly for applications where cost and availability are critical factors.

By Region

The North American region is expected to dominate the infant catheter market, driven by the high prevalence of preterm births and congenital disorders. It is estimated that the North American market will reach approximately USD 500 million by 2035, with a CAGR of 8.0% from 2025 to 2035. The presence of well-established healthcare infrastructure, advanced technology adoption, and a strong emphasis on neonatal care contribute to this growth. Moreover, the increasing number of hospitals and specialized clinics focusing on pediatric care further supports the expansion of the infant catheter market in this region. As healthcare providers continue to enhance patient care standards, North America is expected to maintain its leadership position in the market.

Europe is also anticipated to exhibit significant growth in the infant catheter market, with projections suggesting it will reach around USD 350 million by 2035. The market's growth in Europe can be attributed to the rising incidence of preterm births and the increasing availability of advanced neonatal care solutions. Furthermore, government initiatives aimed at improving maternal and child health, along with investments in healthcare infrastructure, are expected to boost market demand. As the region focuses on enhancing neonatal care practices through the adoption of innovative medical devices, Europe is set to play a crucial role in the overall growth of the infant catheter market.

Opportunities

The infant catheter market presents numerous opportunities for growth and innovation, particularly in the development of advanced catheter technologies. As healthcare providers increasingly seek solutions to improve patient outcomes, there is a growing demand for catheters designed with enhanced biocompatibility, reduced infection risks, and improved user-friendliness. Manufacturers can capitalize on this demand by investing in research and development to create innovative catheter designs tailored to the unique needs of neonates. Additionally, the integration of smart technologies, such as sensors for real-time monitoring and data analytics, can further enhance the safety and efficacy of catheter use in infants. As the focus on personalized medicine continues to evolve, opportunities to create specialized catheters that cater to specific medical conditions or patient populations are likely to emerge.

Moreover, the increasing emphasis on home healthcare presents an opportunity for the infant catheter market. As more families seek to manage their infants' medical needs at home, the demand for user-friendly catheter solutions that allow for safe administration of medications and fluids outside of traditional healthcare settings is expected to grow. Manufacturers that can develop educational resources and support systems for families using catheters at home will be well-positioned to capture this emerging market. Furthermore, expanding distribution channels, such as online retailers, will also facilitate greater access to infant catheters, ultimately enhancing market opportunities for suppliers and healthcare providers alike.

Threats

Despite the promising growth prospects in the infant catheter market, several threats could hinder its expansion. One of the primary concerns is the increasing incidence of catheter-associated complications, such as infections and thrombosis, which can lead to severe adverse outcomes in vulnerable neonates. These complications may result in legal liabilities for healthcare providers and manufacturers, leading to increased scrutiny and regulatory challenges. Additionally, the growing awareness of these risks among healthcare professionals and parents may lead to hesitance in using catheters, particularly in outpatient settings, thereby impacting market growth. The emergence of alternative treatment modalities that minimize the need for invasive procedures could further challenge the demand for infant catheters.

Regulatory hurdles present another significant threat to the infant catheter market. Stringent regulations governing the approval and usage of medical devices can slow down the introduction of innovative catheter solutions. The need for rigorous clinical testing and adherence to safety standards can increase development costs and timeframes, making it difficult for smaller manufacturers to compete. Furthermore, the fluctuating global economy, coupled with potential supply chain disruptions, can affect the availability and affordability of raw materials used in catheter manufacturing. These external factors pose challenges that could restrict the growth of the infant catheter market, necessitating strategic planning by stakeholders.

Competitor Outlook

• Medtronic
• Boston Scientific Corporation
• Smiths Medical
• Teleflex Incorporated
• Terumo Corporation
• B. Braun Melsungen AG
• Cook Group Incorporated
• Cardinal Health
• Halyard Health, Inc.
• AngioDynamics, Inc.
• Vygon S.A.
• ConvaTec Group PLC
• Hollister Incorporated
• Fresenius Kabi AG
• Medline Industries, Inc.

The competitive landscape of the infant catheter market is characterized by a diverse array of key players, each striving to capture market share through innovation and technological advancements. Major companies such as Medtronic and Boston Scientific Corporation lead the industry through their extensive product portfolios and a focus on research and development. These companies have invested significantly in developing advanced catheter technologies, including antimicrobial coatings and smart catheters that enhance patient safety and care quality. As these major players continue to expand their product offerings and optimize their manufacturing processes, they are likely to maintain a competitive edge in the market.

In addition to established players, several mid-sized manufacturers are emerging as noteworthy competitors by specializing in niche products or innovative designs tailored specifically for neonatal care. Companies like Smiths Medical and Teleflex Incorporated are focusing on enhancing the user experience and addressing the specific needs of healthcare providers and patients. By leveraging their expertise in pediatric care and investing in targeted marketing strategies, these firms aim to differentiate themselves in a crowded marketplace. As the demand for specialized medical devices continues to grow, these mid-sized companies are well-positioned to carve out a significant presence within the infant catheter sector.

Furthermore, the increasing trend toward collaborations and partnerships between medical device manufacturers and healthcare institutions is shaping the competitive landscape of the infant catheter market. These alliances facilitate knowledge sharing, improve product development processes, and enhance the understanding of market needs. Companies like Terumo Corporation and B. Braun Melsungen AG are actively engaging in partnerships to leverage their strengths and address the evolving requirements of neonatal care. As this trend continues, the competitive dynamics of the infant catheter market are expected to shift, with an emphasis on collaborative innovation and improved patient outcomes.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Vygon S.A.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Smiths Medical
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Cardinal Health
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Fresenius Kabi AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 ConvaTec Group PLC
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Terumo Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 AngioDynamics, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Halyard Health, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 B. Braun Melsungen AG
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Teleflex Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Hollister Incorporated
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Cook Group Incorporated
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Medline Industries, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Boston Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Infant Catheter Market, By Application
    • 6.1.1 Medication Administration
    • 6.1.2 Fluid and Blood Transfusion
    • 6.1.3 Sampling and Pressure Monitoring
  • 6.2 Infant Catheter Market, By Product Type
    • 6.2.1 Central Venous Catheters
    • 6.2.2 Umbilical Catheters
    • 6.2.3 Peripherally Inserted Central Catheters
    • 6.2.4 Umbilical Arterial Catheters
    • 6.2.5 Neonatal PICC
  • 6.3 Infant Catheter Market, By Material Type
    • 6.3.1 Silicone
    • 6.3.2 Polyurethane
    • 6.3.3 Teflon
    • 6.3.4 Polyethylene
    • 6.3.5 PVC
  • 6.4 Infant Catheter Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Homecare Settings
    • 6.4.5 Online Retailers

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Infant Catheter Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Infant Catheter market is categorized based on

By Product Type

• Central Venous Catheters
• Umbilical Catheters
• Peripherally Inserted Central Catheters
• Umbilical Arterial Catheters
• Neonatal PICC

By Application

• Medication Administration
• Fluid and Blood Transfusion
• Sampling and Pressure Monitoring

By Distribution Channel

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Online Retailers

By Material Type

• Silicone
• Polyurethane
• Teflon
• Polyethylene
• PVC

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Boston Scientific Corporation
• Smiths Medical
• Teleflex Incorporated
• Terumo Corporation
• B. Braun Melsungen AG
• Cook Group Incorporated
• Cardinal Health
• Halyard Health, Inc.
• AngioDynamics, Inc.
• Vygon S.A.
• ConvaTec Group PLC
• Hollister Incorporated
• Fresenius Kabi AG
• Medline Industries, Inc.